5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated interim analysis from Keynote-057: Pembrolizumab monotherapy for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG)
    Meeting Abstract

    Krieger, L.; de Wit, R.; Kulkarni, G. S.; Uchio, E. M.; Boormans, J. L.; Roumiguie, M.; Singer, E. A.; Bajorin, D. F.; Kamat, A. M.; Grivas, P.; more...
    Asia-Pacific Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of prognostic factors and risk groups on overall survival in patients treated with pembrolizumab vs investigator’s choice chemotherapy for advanced urothelial cancer: Post HOC analysis of Keynote-045
    Meeting Abstract

    Gurney, H.; Bellmunt, J.; de Wit, R.; Vaughn, D. J.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; more...
    Asia-Pacific Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Treating HER2-mutant advanced biliary tract cancer with neratinib: Benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket; trial
    Meeting Abstract

    Harding, J.; Cleary, J.; Shapiro, G.; Braña, I.; Moreno, V.; Quinn, D.; Borad, M.; Loi, S.; Spanggaard, I.; Stemmer, S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: Preliminary results
    Meeting Abstract

    Matos, I.; Goyal, L.; Cleary, J.; Voss, M.; Oh, D.; Bernstam, F. M.; Ng, C.; Iyer, G.; Ishii, N.; Hu, Y.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A novel mechanism driving poor-prognosis prostate cancer: Overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Chakraborty, G.; Yoshikawa, Y.; Coggins, S. A.; Nandakumar, S.; Gerke, T. A.; Pomerantz, M. M.; Qiu, X.; Zhao, H.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
    Journal Article

    Liu, Y.; Horn, J. L.; Banda, K.; Goodman, A. Z.; Lim, Y.; Jana, S.; Arora, S.; Germanos, A. A.; Wen, L.; Hardin, W. R.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • Imaging diagnosis and follow-up of advanced prostate cancer: Clinical perspectives and state of the art
    Review

    Perez-Lopez, R.; Tunariu, N.; Padhani, A. R.; Oyen, W. J. G.; Fanti, S.; Vargas, H. A.; Omlin, A.; Morris, M. J.; de Bono, J.; Koh, D. M.
    Radiology (2019)

    Fulltext@MSK | Save
  • Healthy tissue uptake of (68)Ga-prostate-specific membrane antigen, (18)F-DCFPyL, (18)F-fluoromethylcholine, and (18)F-dihydrotestosterone
    Journal Article

    Jansen, B. H. E.; Kramer, G. M.; Cysouw, M. C. F.; Yaqub, M. M.; de Keizer, B.; Lavalaye, J.; Booij, J.; Vargas, H. A.; Morris, M. J.; Vis, A. N.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Reply to L. Dirix, B. De Laere et al, and A. Sharp et al
    Correspondence

    Armstrong, A. J.; Halabi, S.; Luo, J.; Nanus, D. M.; Scher, H. I.; Antonarakis, E. S.; George, D. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Sensitivity of (18)F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
    Journal Article

    Cysouw, M. C. F.; Kramer, G. M.; Heijtel, D.; Schuit, R. C.; Morris, M. J.; van den Eertwegh, A. J. M.; Voortman, J.; Hoekstra, O. S.; Oprea-Lager, D. E.; Boellaard, R.
    EJNMMI Research (2019)

    Fulltext@MSK | Save